Hurley Group signs leases with XRPeds and the BioMed X Institute at Elm City Bioscience Center in New Haven, CT

New Haven, CT Elm City Bioscience Center, a lab and research building in Yale’s university and medical complex, will add two new life science organizations to its 55 Church St. location. The Hurley Group, owner, developer and manager of Elm City Bioscience Center, has signed leases with XRPeds and the BioMed X Institute. The two organizations will be taking occupancy in the facility this summer and fall, respectively.

“We are thrilled to welcome XRPeds and the BioMed X Institute to our community of researchers and innovators at Elm City Bioscience Center,” said David Goldblum, Hurley Group president. “Their presence here reinforces our commitment to providing state-of-the-art laboratory and research space for organizations focused on improving human health and advancing scientific discovery.”

XRPeds, within the Department of Pediatrics at the Yale School of Medicine, focuses on the use of extended reality (virtual, augmented, and mixed reality) and research with the goal of improving lives of youth and their families. Dr. Asher Marks, XRPeds co-director said, “Building upon over 14 years of experience and success in the development and evaluation of XR and game-based health interventions and simulation-based education and research, XRPeds aims to support researchers, clinicians, and educators within Yale Pediatrics in the early stages of exploring and iteratively developing innovative projects utilizing XR technology. At its core, XRPeds is focused on improving the lives of youth and young adults, particularly those at risk for experiencing health disparities associated with race/ethnicity, age, gender, sexual identity, socioeconomic status, and disability.” 

Founded in Heidelberg, Germany, BioMed X is an independent research institute performing biomedical research in collaboration with leading pharmaceutical companies in the fields of oncology, immunology, neuroscience and platform technologies. 

Its location at Elm City Bioscience Center will be the first BioMed X Institute in the US, and its initial project is a collaboration with AbbVie, in the field of immunology & tissue engineering.

The new BioMed X Institute is managed by Mark Johnston, a seasoned biotech entrepreneur. “Elm City Bioscience Center stood out to us not only because of its prime location in the heart of New Haven, but also the cooperation and flexibility they have provided to us. We are looking forward to building and growing our US presence within this vibrant life science innovation ecosystem” said Johnston.

New Haven has become a major hub for the life science ecosystem offering access to world-class talent, venture capital, and partnerships. Elm City Bioscience Center’s state-of-the-art lab suites offer a collaborative community in Downtown New Haven for early and middle-stage biotech companies graduating out of the area’s incubators and other smaller spaces.